Clinical Trials Directory

Trials / Completed

CompletedNCT04666792

PrEParing Family Planning Clinics to Streamline Integration of HIV Prevention Services for Young Women in Kenya

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
25,457 (actual)
Sponsor
University of Washington · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

This a prospective, open-label implementation project to catalyze integration of HIV prevention and PrEP care services for adolescent girls and young women in family planning clinics in Kenya.

Detailed description

Investigators will conduct a stepped-wedge cluster-randomized programmatic project to integrate PrEP provision within a combination HIV prevention package in 12 family planning clinics in Kisumu, Kenya- a region with an HIV prevalence of up to 28% among young women. The project will optimize and sustain PrEP delivery with existing family planning staff, supported through training and ongoing technical assistance. The investigators will rigorously evaluate program reach, effectiveness, adoption, implementation, maintenance, and impact using validated implementation science frameworks and how clinics build new efficient delivery systems.

Conditions

Interventions

TypeNameDescription
DRUGPrEPA fixed-dose, oral co-formulation of emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF) is the approved and preferred regimen for HIV-1 prevention in Kenya and the United States. The World Health Organization (WHO) recommends TDF-containing medications as PrEP, which includes TDF combined with FTC as well as potentially TDF alone and TDF combined with lamivudine (or 3TC, a medication closely related to FTC). Any TDF-containing medications that align with WHO and Kenya national guidelines for PrEP will be used. PrEP medication will come from clinic stocks.

Timeline

Start date
2021-03-01
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2020-12-14
Last updated
2025-09-04

Locations

1 site across 1 country: Kenya

Source: ClinicalTrials.gov record NCT04666792. Inclusion in this directory is not an endorsement.